Leipzig, Germany

Kirstin Scherlach

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kirstin Scherlach: Innovator in Pharmaceutical Research

Introduction

Kirstin Scherlach is a prominent inventor based in Leipzig, Germany. She has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds for medical applications. With a focus on cancer treatment and antimicrobial agents, her work has the potential to impact various therapeutic areas.

Latest Patents

Kirstin Scherlach holds 2 patents that showcase her innovative approach to drug development. Her latest patents include:

1. **Chartreusin analogues** - This invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same, and their use for the treatment of cancer and other diseases.

2. **Benzopyranobenzothiazinones and their use as fungicides, antibiotics, and antitumor agents** - This invention focuses on biologically active compounds, specifically phaeofungins, of the general formula (I) or a pharmacologically acceptable salt, solvate, hydrate, or formulation thereof. It also includes pharmaceutical compositions comprising these compounds and methods for their production, highlighting their use as fungicides, antibiotics, and antitumor agents.

Career Highlights

Throughout her career, Kirstin has worked with esteemed research institutions, including the Leibniz Institute for Natural Product Research and Infection Biology and the Hans Knöll Institute (HKI). Her work in these organizations has allowed her to explore various aspects of natural product chemistry and its applications in medicine.

Collaborations

Kirstin has collaborated with notable scientists in her field, including Christian Hertweck and Hans-Martin Dahse. These collaborations have enriched her research and contributed to the advancement of her innovative projects.

Conclusion

Kirstin Scherlach is a trailblazer in pharmaceutical research, with a focus on developing innovative compounds for treating serious diseases. Her contributions through patents and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…